IMAX Crosses Above Average Analyst Target

IMAX Corp. (IMAX) shares have recently surpassed the average analyst 12-month target price of $33.64, trading at $33.70/share. This development typically prompts analysts to either downgrade their valuation or raise their price targets, often influenced by underlying business fundamentals. For institutional investors, this signals a critical juncture to reassess IMAX's valuation, weighing the stock's upward momentum against the prevailing analyst consensus, which remains largely positive with an average rating of 1.67 (Strong Buy).

Analysis

In recent trading, shares of IMAX Corp. (Symbol: IMAX) have crossed above the average analyst 12-month target price of $33.64, changing hands for $33.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher — if things are looking up for the company, perhaps it is time for that target price to be raised. There are 11 different analyst targets within the Zacks coverage universe contributing to that average for IMAX Corp., but the average is just that — a mathematical average. There are analysts with lower targets than the average, including one looking for a price of $18.00. And then on the other side of the spectrum one analyst has a target as high as $39.00. The standard deviation is $6.021. But the whole reason to look at the average IMAX price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. And so with IMAX crossing above that average target price of $33.64/share, investors in IMAX have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $33.64 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? Below is a table showing the current thinking of the analysts that cover IMAX Corp.: | Recent IMAX Analyst Ratings Breakdown | |||| |---|---|---|---|---| | » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago | | Strong buy ratings: | 9 | 9 | 9 | 9 | | Buy ratings: | 0 | 0 | 0 | 0 | | Hold ratings: | 2 | 2 | 2 | 2 | | Sell ratings: | 0 | 0 | 0 | 0 | | Strong sell ratings: | 1 | 1 | 1 | 1 | | Average rating: | 1.67 | 1.67 | 1.67 | 1.67 | The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. This article used data provided by Zacks Investment Research via Quandl.com. Get the latest Zacks research report on IMAX — FREE. 10 ETFs With Most Upside To Analyst Targets » Also see: Funds Holding MYC GS 13F Filers Institutional Holders of MIFI The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. IMAX Corp.'s stock has breached a key psychological and technical level, trading at $33.70 per share and narrowly surpassing the average 12-month analyst price target of $33.64. This event serves as an inflection point, prompting a re-evaluation of the stock's valuation. While the consensus rating from 12 analysts remains a firmly bullish 1.67 (where 1 is a Strong Buy), with 9 of 11 covering analysts maintaining a 'Strong Buy' rating, the price targets themselves exhibit significant dispersion. The targets range from a low of $18.00 to a high of $39.00, with a standard deviation of $6.021, indicating a lack of consensus on the ultimate valuation ceiling despite the positive sentiment. The stability of the analyst ratings over the past three months suggests the current bullish stance is well-entrenched, but the stock's price action now challenges this consensus and will likely force analysts to either upgrade targets, signaling belief in further fundamental upside, or downgrade on valuation, potentially capping the stock's rally.

Key Decisions for Investors

• Investors holding IMAX should consider the stock's proximity to the average price target as a potential trigger to review their position and potentially trim holdings to lock in gains, as valuation concerns may now become more prominent.
• The wide dispersion in analyst price targets, with a standard deviation of $6.02, alongside the presence of one 'Strong Sell' rating, warrants a thorough examination of the bearish case to stress-test the prevailing bullish consensus.
• Monitor upcoming analyst reports closely, as target price upgrades would serve as a strong confirmation of continued momentum, whereas downgrades or a shift from 'Strong Buy' to 'Hold' could signal a near-term top for the stock.